Dietmar Berger's Insider Trades & SAST Disclosures

Dietmar Berger's most recent trade in Gilead Sciences, Inc. was a trade of 37,710 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 10, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Gilead Sciences, Inc.
Dietmar Berger Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 37,710 37,710 - - Non-qualified Stock Option (Right to Buy)
Gilead Sciences, Inc.
Dietmar Berger Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 8,530 57,505 - - Restricted Stock Unit
Gilead Sciences, Inc.
Dietmar Berger Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 48,975 48,975 - - Restricted Stock Unit
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades